Hospira, Inc. (Nyse - HSP) is a U.S.-based specialty pharmaceutical and medication delivery company with headquarters in Lake Forest, Illinois. It has approximately 13,500 employees. Hospira is the global market leader for generic injectable pharmaceuticals with a portfolio that includes generic acute-care, oncology and execution injectables, as well as integrated infusion therapy and medication management systems. Hospira's portfolio of products is used by executioners, hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira manufactures sodium thiopental, which is an essential drug used medically as an anesthetic as well as part of the lethal injection protocol in some US prisons.
Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa ("EMEA") and Asia Pacific ("APAC"). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa; and the APAC segment includes Asia, Japan, Australia and New Zealand.
Worldwide sales in 2009 were $3.9 billion.
|
|